BBLGW Bone Biologics Corp - warrants
4.060USD0.00%Mkt Cap: —P/E: —14d ago
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromoti…
Industry Peers
Chemicals$49.76BUSDP/E 21.6
$20.06BUSD
$8.75BUSD
$4.81BUSD
$4.86BUSDP/E 61.6
$4.67BUSDP/E 59.8
$4.05BUSDP/E 34.2
$2.82BUSDP/E 826.7
$2.65BUSDP/E 17.4
$2.04BUSDP/E 15.0
$1.79BUSDP/E 17.0
$1.81BUSD
$1.49BUSDP/E 14.7
$1.51BUSD
$1.47BUSDP/E 12.1
$1.18BUSDP/E 11.2
$1.08BUSDP/E 9.5
$1.25BUSD
$753.56MUSDP/E 13.0
$734.37MUSDP/E 20.4
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.11M USD
Revenue/Share—
Last Price4.060 USD
Fiscal Year End—
MR Quarter—
Employees2
CountryUS
SectorBasic Materials
IndustryChemicals
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.01
EPS (TTM)-0.14
EPS (Forward)—
52W Range
3.5002% of range35.95
52W High35.95 USD
52W Low3.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-57.81%
ROA-53.64%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.69M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-4.03M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio8.66
Quick Ratio7.89
Book Value/Sh2.17 USD
Cash/Share1.46 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float2.76M
Insiders—
Institutions—
Technical
SMA 506.444 (-37.0%)
SMA 20015.85 (-74.4%)
Beta0.57
S&P 52W Chg15.78%
Avg Vol (30d)1.01K
Avg Vol (10d)1.28K
Technical Indicators
RSI (14)31.2
MACD-1.7539
MACD Signal-1.7649
MACD Hist.+0.0110
BB Upper9.436 USD
BB Middle6.002 USD
BB Lower2.567 USD
BB Width114.44%
ATR (14)0.9144 USD
Vol Ratio (20d)0.00x